Efficacy of three statins at lower maintenance doses

Area of Science:

• Cardiology
• Pharmacology
• Clinical Therapeutics

Background:

• Hyperlipidemia management often involves statin therapy.
• Lovastatin is a commonly prescribed statin for cholesterol control.
• Exploring alternative statin regimens is crucial for patient management and adherence.

Purpose of the Study:

• To assess the efficacy and safety of switching from lovastatin 20 mg daily to lower doses of lovastatin or alternative statins.
• To determine if lipid control is maintained and side effects are comparable across different statin regimens.

Main Methods:

• A randomized controlled trial involving 105 patients with stable lipid levels on lovastatin 20 mg/d.
• Patients were randomized to continue lovastatin 20 mg/d or switch to lovastatin 10 mg, pravastatin 10 mg, or simvastatin 5 mg daily.
• Evaluations included lipid profiles, liver enzymes, and muscle enzymes at baseline and after 12 weeks.

Main Results:

• Switching to pravastatin 10 mg or simvastatin 5 mg did not significantly alter mean total cholesterol levels.
• Patients switched to lovastatin 10 mg experienced a statistically significant increase in mean total cholesterol.
• No significant differences in side effects or elevations in liver/muscle enzymes were observed across groups.

Conclusions:

• Patients on stable lovastatin 20 mg/d can be safely switched to pravastatin 10 mg/d or simvastatin 5 mg/d without compromising lipid control.
• Lovastatin 10 mg/d may not be a suitable alternative for maintaining lipid control in patients stabilized on lovastatin 20 mg/d.
• These findings support individualized statin therapy adjustments based on patient response and therapeutic goals.